These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3729722)

  • 21. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Parkinson JE; Smith GL
    Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge.
    Lustig S; Fogg C; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
    J Virol; 2005 Nov; 79(21):13454-62. PubMed ID: 16227266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antigenicity and immunogenicity of the intracellular and extracellular forms of vaccinia virus. I: The production of high-titre vaccinia extracellular virus and its antigenicity after inactivation.
    Thornton B
    Br J Exp Pathol; 1980 Aug; 61(4):444-50. PubMed ID: 7426394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement.
    Lustig S; Fogg C; Whitbeck JC; Moss B
    Virology; 2004 Oct; 328(1):30-5. PubMed ID: 15380355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation.
    Vanderplasschen A; Hollinshead M; Smith GL
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():2041-8. PubMed ID: 9267005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of Varicella-zoster virus.
    Kutinová L; Hainz P; Ludvíková V; Maresová L; Nĕmecková S
    Virology; 2001 Feb; 280(2):211-20. PubMed ID: 11162835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine.
    Payne LG; Kristenson K
    J Virol; 1979 Nov; 32(2):614-22. PubMed ID: 501802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus.
    Wolffe EJ; Katz E; Weisberg A; Moss B
    J Virol; 1997 May; 71(5):3904-15. PubMed ID: 9094667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccinia virus immune evasion.
    Smith GL
    Immunol Lett; 1999 Jan; 65(1-2):55-62. PubMed ID: 10065628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immune response to vaccinia virus infection in mice: analysis of the role of antibody.
    Novembre FJ; Raska K; Holowczak JA
    Arch Virol; 1989; 107(3-4):273-89. PubMed ID: 2684096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
    Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
    Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of neutralizing antibodies against bovine leukosis virus in rabbits by vaccination with recombinant vaccinia virus expressing bovine leukosis virus envelope glycoprotein.
    Ohishi K; Suzuki H; Maruyama T; Yamamoto T; Funahashi S; Miki K; Ikawa Y; Sugimoto M
    Am J Vet Res; 1990 Aug; 51(8):1170-3. PubMed ID: 2167028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus.
    Maa JS; Esteban M
    J Virol; 1987 Dec; 61(12):3910-9. PubMed ID: 3316708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.
    Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S
    J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6.
    Aldaz-Carroll L; Xiao Y; Whitbeck JC; de Leon MP; Lou H; Kim M; Yu J; Reinherz EL; Isaacs SN; Eisenberg RJ; Cohen GH
    J Virol; 2007 Aug; 81(15):8131-9. PubMed ID: 17522205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactivity among cowpox, ectromelia and vaccinia viruses with monoclonal antibodies recognizing distinct antigenic determinants in A-type inclusion bodies.
    Kitamoto N; Tanimoto S; Hiroi K; Miyamoto H; Wakamiya N; Ueda S; Kato S
    Arch Virol; 1986; 91(3-4):357-66. PubMed ID: 2430550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo.
    Lin CL; Chung CS; Heine HG; Chang W
    J Virol; 2000 Apr; 74(7):3353-65. PubMed ID: 10708453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant vaccinia virus: immunization against multiple pathogens.
    Perkus ME; Piccini A; Lipinskas BR; Paoletti E
    Science; 1985 Sep; 229(4717):981-4. PubMed ID: 2992092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
    Fogg C; Lustig S; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
    J Virol; 2004 Oct; 78(19):10230-7. PubMed ID: 15367588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular vesicles containing virus-encoded membrane proteins are a byproduct of infection with modified vaccinia virus Ankara.
    Spehner D; Drillien R
    Virus Res; 2008 Oct; 137(1):129-36. PubMed ID: 18662728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.